Mesa Laboratories (MLAB) Competitors $69.28 +6.01 (+9.50%) Closing price 08/13/2025 04:00 PM EasternExtended Trading$69.15 -0.13 (-0.19%) As of 08/13/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLAB vs. FARO, DAKT, VPG, COHR, CGNX, ITRI, BMI, OSIS, IART, and OPKShould you be buying Mesa Laboratories stock or one of its competitors? The main competitors of Mesa Laboratories include FARO Technologies (FARO), Daktronics (DAKT), Vishay Precision Group (VPG), Coherent (COHR), Cognex (CGNX), Itron (ITRI), Badger Meter (BMI), OSI Systems (OSIS), Integra LifeSciences (IART), and OPKO Health (OPK). Mesa Laboratories vs. Its Competitors FARO Technologies Daktronics Vishay Precision Group Coherent Cognex Itron Badger Meter OSI Systems Integra LifeSciences OPKO Health Mesa Laboratories (NASDAQ:MLAB) and FARO Technologies (NASDAQ:FARO) are both small-cap electronic equipment & instruments companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership. Do insiders & institutionals have more ownership in MLAB or FARO? 90.6% of Mesa Laboratories shares are owned by institutional investors. Comparatively, 97.2% of FARO Technologies shares are owned by institutional investors. 4.9% of Mesa Laboratories shares are owned by company insiders. Comparatively, 2.1% of FARO Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor MLAB or FARO? In the previous week, Mesa Laboratories had 7 more articles in the media than FARO Technologies. MarketBeat recorded 7 mentions for Mesa Laboratories and 0 mentions for FARO Technologies. Mesa Laboratories' average media sentiment score of 1.03 beat FARO Technologies' score of 0.00 indicating that Mesa Laboratories is being referred to more favorably in the media. Company Overall Sentiment Mesa Laboratories Positive FARO Technologies Neutral Which has better valuation and earnings, MLAB or FARO? Mesa Laboratories has higher earnings, but lower revenue than FARO Technologies. FARO Technologies is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMesa Laboratories$240.98M1.58-$1.97M-$0.14-494.86FARO Technologies$342.43M2.48-$9.07M-$0.05-879.80 Do analysts prefer MLAB or FARO? Mesa Laboratories currently has a consensus price target of $113.50, indicating a potential upside of 63.83%. FARO Technologies has a consensus price target of $35.50, indicating a potential downside of 19.30%. Given Mesa Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe Mesa Laboratories is more favorable than FARO Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mesa Laboratories 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50FARO Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, MLAB or FARO? Mesa Laboratories has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, FARO Technologies has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Is MLAB or FARO more profitable? Mesa Laboratories' return on equity of 24.49% beat FARO Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Mesa Laboratories-0.26% 24.49% 9.03% FARO Technologies -0.26%-0.35%-0.18% SummaryMesa Laboratories beats FARO Technologies on 10 of the 15 factors compared between the two stocks. Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLAB vs. The Competition Export to ExcelMetricMesa LaboratoriesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$348.08M$6.97B$5.54B$9.82BDividend Yield1.01%1.31%4.62%4.11%P/E Ratio-494.8625.2030.1526.03Price / Sales1.5868.92461.34104.73Price / Cash5.1621.6737.7558.93Price / Book2.215.698.496.06Net Income-$1.97M$176.29M$3.26B$265.11M7 Day Performance9.15%4.88%4.19%3.38%1 Month Performance-16.39%0.25%4.64%2.28%1 Year Performance-43.80%14.35%35.15%29.67% Mesa Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLABMesa Laboratories3.8313 of 5 stars$69.28+9.5%$113.50+63.8%-44.8%$348.08M$240.98M-494.86680FAROFARO Technologies1.5296 of 5 stars$43.99flat$35.50-19.3%N/A$849.89M$342.43M-879.801,232DAKTDaktronics4.5997 of 5 stars$16.92-0.5%$26.00+53.7%+17.4%$834.93M$756.48M-38.452,702VPGVishay Precision Group1.3305 of 5 stars$26.26-3.5%$28.50+8.5%+1.1%$360.60M$306.52M-291.702,200COHRCoherent3.4222 of 5 stars$113.64-1.6%$105.40-7.3%+70.5%$17.94B$4.71B-494.0826,157Trending NewsAnalyst ForecastGap UpCGNXCognex4.5046 of 5 stars$40.47-1.1%$42.31+4.5%+12.8%$6.87B$914.52M57.002,914ITRIItron4.4598 of 5 stars$123.98-1.2%$136.25+9.9%+32.7%$5.74B$2.44B21.195,788News CoverageBMIBadger Meter4.448 of 5 stars$188.81+0.3%$238.40+26.3%-0.6%$5.55B$826.56M41.142,210Positive NewsDividend IncreaseOSISOSI Systems3.5045 of 5 stars$224.22-0.8%$228.33+1.8%+69.3%$3.79B$1.54B27.286,681Positive NewsUpcoming EarningsHigh Trading VolumeIARTIntegra LifeSciences4.0041 of 5 stars$12.75-1.6%$18.63+46.1%-34.8%$1.01B$1.61B-1.954,396OPKOPKO Health4.6269 of 5 stars$1.30+4.0%$2.75+111.5%-11.2%$992.23M$713.10M-5.202,997Gap Up Related Companies and Tools Related Companies FARO Alternatives DAKT Alternatives VPG Alternatives COHR Alternatives CGNX Alternatives ITRI Alternatives BMI Alternatives OSIS Alternatives IART Alternatives OPK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MLAB) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access